Amphenol Corp (APH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,128,000 | 11,130,600 | 3,799,300 | 3,207,000 | 1,657,200 |
| Marketable Securities | 455,100 | 303,600 | 88,800 | 19,400 | 14,500 |
| Receivables | 5,872,900 | 4,717,100 | 4,543,800 | 4,270,900 | 3,920,300 |
| Inventories | 4,086,800 | 3,424,900 | 3,300,100 | 3,137,100 | 2,906,400 |
| TOTAL | $15,383,700 | $20,267,200 | $12,383,900 | $11,298,500 | $9,133,200 |
| Non-Current Assets | |||||
| PPE Net | 2,688,600 | 2,305,600 | 2,141,500 | 2,053,900 | 1,854,900 |
| Intangibles | 22,944,000 | 12,816,800 | 11,850,900 | 11,640,700 | 11,275,800 |
| Other Non-Current Assets | 1,117,500 | 847,300 | 766,700 | 675,300 | 638,200 |
| TOTAL | $26,750,100 | $15,969,700 | $14,759,100 | $14,369,900 | $13,768,900 |
| Total Assets | $42,133,800 | $36,236,900 | $27,143,000 | $25,668,400 | $22,902,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,109,600 | 937,200 | 937,600 | 936,600 | 350,800 |
| Accounts payable and accrued liabilities | 3,181,500 | 2,661,900 | 2,462,400 | 2,373,000 | 2,142,400 |
| Accrued Expenses | 982,900 | 1,074,400 | 890,500 | 804,600 | 934,400 |
| TOTAL | $8,974,700 | $6,802,800 | $5,983,900 | $5,604,200 | $4,591,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 16,639,300 | 14,564,800 | 7,129,500 | 7,125,800 | 6,816,100 |
| Other Non-Current Liabilities | 1,157,000 | 926,300 | 1,045,900 | 970,700 | 738,700 |
| TOTAL | $19,076,700 | $15,933,700 | $8,562,400 | $8,474,600 | $7,948,000 |
| Total Liabilities | $28,051,400 | $22,736,500 | $14,546,300 | $14,078,800 | $12,539,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,230,234 | 1,229,215 | 1,224,056 | 1,220,921 | 1,209,599 |
| Common Shares | 1,200 | 1,200 | 1,200 | 1,200 | 1,200 |
| Retained earnings | 10,432,100 | 9,854,300 | 9,155,000 | 8,135,200 | 7,445,900 |
| Other shareholders' equity | -388,300 | -392,000 | -431,200 | -399,500 | -582,200 |
| TOTAL | $14,082,400 | $13,500,400 | $12,596,700 | $11,589,600 | $10,363,100 |
| Total Liabilities And Equity | $42,133,800 | $36,236,900 | $27,143,000 | $25,668,400 | $22,902,100 |